BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1614 related articles for article (PubMed ID: 34976920)

  • 1. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of the Chinese Government's Efforts to Fight COVID-19: Integration of Top-Down Interventions and Local Governance.
    Gao J; Zhang P
    Health Secur; 2022; 20(4):348-356. PubMed ID: 35787156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the nexus between COVID-19 pandemic-driven economic crisis and economic policy: lesson learned and challenges.
    Chang L; Mohsin M; Iqbal W
    Environ Sci Pollut Res Int; 2023 Feb; 30(9):22145-22158. PubMed ID: 36282386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Caused the Outbreak of COVID-19 in China: From the Perspective of Crisis Management.
    Shangguan Z; Wang MY; Sun W
    Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32397199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 emergencies around the globe: China's experience in controlling COVID-19 and lessons learned.
    Jin H; Lu L; Liu J; Cui M
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33320189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. China's community-based crisis management model for COVID-19: A zero-tolerance approach.
    Shangguan Z; Wang MY
    Front Public Health; 2022; 10():880479. PubMed ID: 35937237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community Resilience Governance on Public Health Crisis in China.
    Wang C; Dong X; Zhang Y; Luo Y
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33671618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons Learned From the Resilience of Chinese Hospitals to the COVID-19 Pandemic: Scoping Review.
    Stennett J; Hou R; Traverson L; Ridde V; Zinszer K; Chabrol F
    JMIRx Med; 2022; 3(2):e31272. PubMed ID: 35435649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doctor of Public Health-Crisis Management and COVID-19 Prevention and Control: A Case Study in China.
    Cai W; Gao R; Jing Q; Wang C; Hou N; Liu W; Gao Q; Sun X
    Front Public Health; 2022; 10():814632. PubMed ID: 35186846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in China: Power, Transparency and Governance in Public Health Crisis.
    Zhang J; Zhang R
    Healthcare (Basel); 2020 Aug; 8(3):. PubMed ID: 32842607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What accounts for the different regional responses to COVID-19 in China? Exploring the role of institutional environment, governance capacity and legitimacy.
    Mao Y
    Health Policy Plan; 2023 Apr; 38(4):552-566. PubMed ID: 36715072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensating for the 'Authoritarian Advantage' in Crisis Response: A Comparative Case Study of SARS Pandemic Responses in China and Taiwan.
    Schwartz J
    J Chin Polit Sci; 2012; 17(3):313-331. PubMed ID: 32288475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Institutional Network Relationship of Chinese Public Crisis Governance System-Based on the Quantitative Comparative Analysis of Policies during SARS and COVID-19.
    Yang J; Huang W
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Government Information Dissemination During Public Health Emergencies: An Analysis of China's Experiences.
    Zhang Y; Shan J; Ye Z
    Front Public Health; 2022; 10():748236. PubMed ID: 35392466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy disparities in response to the first wave of COVID-19 between China and Germany.
    Zhang Y; Shi L; Chen H; Wang X; Sun G
    Int J Equity Health; 2021 Mar; 20(1):86. PubMed ID: 33766049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. China's Fight Against COVID-19: What We Have Done and What We Should Do Next?
    Cheng S; Zhao Y; Kaminga AC; Zhang X; Xu H
    Front Public Health; 2022; 10():548056. PubMed ID: 35844877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Post-Pandemic World: between Constitutionalized and Authoritarian Orders - China's Narrative-Power Play in the Pandemic Era.
    Chang YY
    J Chin Polit Sci; 2021; 26(1):27-65. PubMed ID: 33071536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crisis management in authoritarian regimes: A comparative study of COVID-19 responses in Turkey and Iran.
    San S; Bastug MF; Basli H
    Glob Public Health; 2021 Apr; 16(4):485-501. PubMed ID: 33378230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.